AnovaOS Network Powered Patient Registry
Part of paid clinical trials in Arlington Heights, Illinois.
- Sponsor
- Anova Enterprises, Inc
- Study ID
- NCT05013944
- Status
- Recruiting
Conditions
- Certain Conditions Originating in the Perinatal Period
- Congenital Malformations, Deformations and Chromosomal Abnormalities (Q00-Q99)
- Diseases of the Blood and Blood-Forming Organs and Certain Disorders Involving the Immune Mechanism (D50-D89)
- Diseases of the Circulatory System
- Diseases of the Digestive System
- Diseases of the Ear and Mastoid Process
- Diseases of the Eye and Adnexa
- Diseases of the Genitourinary System
- Diseases of the Musculoskeletal System and Connective Tissue
- Diseases of the Nervous System
- Diseases of the Respiratory System
- Diseases of the Skin and Subcutaneous Tissue
- Endocrine, Nutritional and Metabolic Diseases (E00-E89)
- External Causes of Morbidity and Mortality
- Factors Influencing Health Status and Contact With Health Services
- Infectious Disease
- Injury, Poisoning and Certain Other Consequences of External Causes
- Mental and Behavioural Disorders
- Neoplasms
- Pregnancy, Childbirth and the Puerperium
- Symptoms, Signs and Abnormal Clinical and Laboratory Findings, Not Elsewhere Classified
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Accepted
Study Details
The objective of this study is the development, implementation and management of a registry of patient data that captures clinically meaningful, real-world, data on the diagnosis, nature, course of infection, treatment(s) and outcomes in patients with complex disease globally.
Key Dates
- Start date
- Sep 1, 2021
- Status verified
- Jan 2024
- Primary completion
- Aug 31, 2025
- Completion
- Aug 31, 2026
Study Design
- Enrollment
- 100,000 participants (estimated)
Primary Outcome Measure
Assess Natural history [ Time Frame: 5 years ]
Central Contacts
- Christopher Beardmore+1 (224) 218-2408
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Anova Enterprises, Inc. | Arlington Heights | Illinois | 60005 | Christopher Beardmore (PRINCIPAL_INVESTIGATOR) |
Find similar trials in Arlington Heights, IL
By research site
Related Studies
- Registry Study for Radiation Therapy OutcomesRecruiting · Proton Collaborative Group · Scottsdale, Arizona
- Long-Term Follow-up Protocol for Participants Treated With Gene-Modified T CellsPHASE2/PHASE3 · Recruiting · Celgene · Birmingham, Alabama
- Safety of SBRT With Anti-PD1 and Anti-IL-8 for the Treatment of Multiple Metastases in Advanced Solid Tumors and MelanomaPHASE1 · Recruiting · Yana Najjar · Chicago, Illinois
- Study of Abemaciclib and Elacestrant in Participants With Brain Metastasis Due to ER+/HER-2- Breast CancerPHASE1/PHASE2 · Recruiting · Stemline Therapeutics, Inc. · Fullerton, California